À retenir
Pooling 20 case-control studies, the overall odds ratio linking sarcopenia and dyslipidemia in older adults was 1.47. The association was strongly region-dependent (OR 4.38 outside China, 0.9 in China), and the abstract gives no confidence intervals, so the strength and consistency of the link are uncertain.
Study design
Revue des preuves
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Sarcopenia is loss of muscle in older people, and reports disagree on whether abnormal blood fats are connected to it. The authors pooled case-control studies to test whether dyslipidemia goes along with sarcopenia, and how lipid levels differ between people with and without it.
Population et méthode
Meta-analysis of case-control studies. The authors searched the Cochrane Library, Web of Science, PubMed, CNKI, Wan Fang and VIP databases and extracted the odds ratio (OR) for sarcopenia and dyslipidemia, and mean differences (MD) in total cholesterol (TC), LDL cholesterol (LDL-C), HDL cholesterol (HDL-C), triglycerides (TG) and TG/HDL-C between people with and without sarcopenia. Quality was assessed with Joanna Briggs Institute guidelines, and statistics used Excel 2021, Review Manager 5.3 and Stata 16.0. Twenty studies were included, 19 rated good quality.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1The overall OR for the relationship between sarcopenia and dyslipidemia was 1.47, meaning higher odds of dyslipidemia in people with sarcopenia.
- 2The pooled mean differences between sarcopenia and non-sarcopenia were 1.10 for TC, 1.95 for LDL-C, 1.27 for HDL-C, 30.13 for TG and 0.16 for TG/HDL-C. The abstract does not give units or confidence intervals.
- 3By region, the OR was 4.38 outside China and 0.9 in China. By age, the mean difference in TC was 2.63 in the over-60 group versus 1.54 in the 20-60 group.
- 4Results differed by sex: in women the mean differences for TC, LDL-C, HDL-C and TG were -1.67, 2.21, 1.02 and -3.18, and in men -0.51, 1.41, 5.77 and -0.67.
Limites et incertitude
- 1Case-control studies cannot show whether lipid abnormalities lead to muscle loss or the reverse, and other factors such as diet, obesity and inactivity may explain both.
- 2The pooled OR for China was 0.9 and 4.38 elsewhere, a big inconsistency; the abstract gives no heterogeneity statistics or confidence intervals to judge it.
- 3Sex and age subgroup results are inconsistent in direction, for example TC differences of -1.67 in women and 2.63 in the over-60 group.
- 4This reading is based on the abstract only, which omits units and definitions of dyslipidemia and sarcopenia.
Mise en perspective
Abnormal blood lipids and low muscle mass tend to show up together in older adults, but this review cannot tell you that fixing one improves the other. Lipid results and muscle loss concerns are best interpreted by a clinician in the context of your age, sex and health.
Vos données
Blood lipids come from lab tests, not wearables. For the muscle side, body weight, strength-training sessions and grip or sit-to-stand tests you do yourself can be tracked over months on the same scale or at the same gym setup; a smart scale's muscle mass estimate is rough, so trust the trend more than the number.
Comprendre ce type de preuve
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Purpose
Sarcopenia is a pathological change characterized by muscle loss in older people. According to the reports, there is controversy on the relationship between dyslipidemia and sarcopenia. Therefore, this meta-analysis aimed to explore the association between sarcopenia and dyslipidemia.
Methods
We searched the Cochrane Library, Web of Science, PubMed, China National Knowledge Infrastructure (CNKI), Wan Fang, China Science and Technology Journal Database (VIP Database) for case‒control studies to extract data on the odds ratio (OR) between sarcopenia and dyslipidemia and the MD(mean difference) of TC, LDL-C, HDL-C, TG, and TG/HDL-C between sarcopenia and nonsarcopenia. The JBI(Joanna Briggs) guidelines were used to evaluate the quality. Excel 2021, Review Manager 5.3 and Stata 16.0 were used for the statistical analysis.
Results
Twenty studies were included in the meta-analysis, 19 of which were evaluated as good quality. The overall OR of the relationship between sarcopenia and dyslipidemia was 1.47, and the MD values of TC, LDL-C, HDL-C, TG, and TG/HDL-C were 1.10, 1.95, 1.27, 30.13, and 0.16 respectively. In female, compared with the non-sarcopnia, the MD of TC, LDL-C, HDL-C, TG of sarcopenia were - 1.67,2.21,1.02,-3.18 respectively. In male, the MD of TC, LDL-C, HDL-C, TG between sarcopenia and non-sarcopenia were - 0.51, 1.41, 5.77, -0.67. The OR between sarcopenia and dyslipidemia of the non-China region was 4.38, and it was 0.9 in China. In the group(> 60), MD of TC between sarcopenia and non-sarcopenia was 2.63, while it was 1.54 in the group(20-60).
Conclusion
Dyslipidemia was associated with sarcopenia in the elderly, which was affected by sex, region and age.
Sources et attribution
Dyslipidemia is associated with sarcopenia of the elderly: a meta-analysis.
Bi B, Dong X, Yan M, Zhao Z, Liu R, Li S, Wu H.
BMC geriatrics · 2024-02-23
DOI: 10.1186/s12877-024-04761-4 ↗PubMed · 38395763 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

